Inventor · disambiguated record
Benedikt Steitz
Also filed as: STEITZ BENEDIKT
8 granted patents·12 pending applications·42 citations·filing 2009–2024
85Inventor score
Top patents by PatentIndex Score
20 records- 0196US11633396B2Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-oneKUDOS PHARM LTD·Filed 2022·Granted Apr 25, 2023·8 cites·30 claims
- 0290US12178816B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2024·Granted Dec 31, 2024·0 cites·30 claims
- 0390US12144810B1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2024·Granted Nov 19, 2024·0 cites·30 claims
- 0490US8475842B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneBECHTOLD MICHAEL KARL·Filed 2009·Granted Jul 2, 2013·21 cites·10 claims
- 0586US12048695B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 0686US11975001B2Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-oneKUDOS PHARM LTD·Filed 2023·Granted May 7, 2024·0 cites·13 claims
- 0779US9060986B2Delivery system for sustained release of a calcium-channel blocking agentBREITENBACH JORG·Filed 2010·Granted Jun 23, 2015·13 cites·8 claims
- 0878US2022249474A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 0972US2020323847A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneASTRAZENECA UK LTD·Filed 2020·Application pending·0 cites
- 1069US2019365751A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneASTRAZENECA UK LTD·Filed 2018·Application pending·0 cites
- 1166US2024075026A1Solid Pharmaceutical Compositions for Treating HCVABBVIE INC·Filed 2023·Application pending·0 cites
- 1265US2018133216A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneASTRAZENECA UK LTD·Filed 2017·Application pending·0 cites
- 1364US11246866B2Solid pharmaceutical compositions for treating HCVABBVIE INC·Filed 2019·Granted Feb 15, 2022·0 cites·27 claims
- 1464US2017173010A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneASTRAZENECA UK LTD·Filed 2017·Application pending·0 cites
- 1563US2014066447A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneASTRAZENECA UK LTD·Filed 2013·Application pending·0 cites
- 1660US2020282004A1Solid Pharmaceutical Compositions for Treating HCVABBVIE INC·Filed 2019·Application pending·0 cites
- 1758US2016008473A1Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-oneASTRAZENECA UK LTD·Filed 2015·Application pending·0 cites
- 1850US2016375017A1Solid Pharmaceutical Compositions for Treating HCVABBVIE INC·Filed 2016·Application pending·0 cites
- 1948US2019216882A1Solid Pharmaceutical Compositions for Treating HCVABBVIE INC·Filed 2018·Application pending·0 cites
- 2041US2016375087A1Solid Pharmaceutical Compositions for Treating HCVABBVIE INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Benedikt Steitz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →